NCT03113994 Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk Status TERMINATED Phase PHASE2
NCT03087851 Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis Status COMPLETED Phase PHASE4
NCT03076034 Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk Status ACTIVE_NOT_RECRUITING Phase NA
NCT03051620 Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate Status COMPLETED Phase N/A
NCT03040765 Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis Status TERMINATED Phase PHASE3
NCT02967978 Study on the Predictive Value of the Natural Calcium Isotope Ratio in Urine and Serum for the Diagnosis of Osteoporosis Status COMPLETED Phase N/A
NCT02948881 A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo Status COMPLETED Phase PHASE4
NCT02944799 Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT02931305 Epimedium Prenylflavonoid (EP) Extract for Osteoporosis and Cardiovascular Disease Status UNKNOWN Phase PHASE1
NCT02924545 Evaluation of Osteoporosis Support After a Severe Osteoporotic Fracture in Women Over 50 Years in University Hospital Status COMPLETED Phase N/A
NCT02916862 Effect of Soluble Corn Fiber Supplementation for 1 Year on Bone Metabolism in Adolescents Status COMPLETED Phase PHASE2